EA201401277A1 - Соединения метантиона, обладающие противовирусной активностью - Google Patents

Соединения метантиона, обладающие противовирусной активностью

Info

Publication number
EA201401277A1
EA201401277A1 EA201401277A EA201401277A EA201401277A1 EA 201401277 A1 EA201401277 A1 EA 201401277A1 EA 201401277 A EA201401277 A EA 201401277A EA 201401277 A EA201401277 A EA 201401277A EA 201401277 A1 EA201401277 A1 EA 201401277A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methantion
compounds
virus activity
compound
formula
Prior art date
Application number
EA201401277A
Other languages
English (en)
Other versions
EA029044B1 (ru
Inventor
Мохаммед Хомман
Нгарита Кинги
Ян Бергман
Роберт Берг
Original Assignee
Виронова Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48444409&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201401277(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Виронова Аб filed Critical Виронова Аб
Publication of EA201401277A1 publication Critical patent/EA201401277A1/ru
Publication of EA029044B1 publication Critical patent/EA029044B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Соединение формулы (I)которое применимо в качестве противовирусного средства, в частности, для лечения гриппа. Способ получения соединения формулы (I) и композиция, содержащая соединение формулы (I).
EA201401277A 2012-05-18 2013-05-17 Соединения метантиона, обладающие противовирусной активностью EA029044B1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648700P 2012-05-18 2012-05-18
US201261659516P 2012-06-14 2012-06-14
US201261666286P 2012-06-29 2012-06-29
US201361774991P 2013-03-08 2013-03-08
PCT/EP2013/060266 WO2013171334A1 (en) 2012-05-18 2013-05-17 Methanethione compounds having antiviral activity

Publications (2)

Publication Number Publication Date
EA201401277A1 true EA201401277A1 (ru) 2015-04-30
EA029044B1 EA029044B1 (ru) 2018-02-28

Family

ID=48444409

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201401277A EA029044B1 (ru) 2012-05-18 2013-05-17 Соединения метантиона, обладающие противовирусной активностью

Country Status (20)

Country Link
US (1) US9359310B2 (ru)
EP (1) EP2870141B1 (ru)
JP (2) JP6484168B2 (ru)
KR (1) KR102092207B1 (ru)
CN (1) CN104540810B (ru)
AU (1) AU2013261735B2 (ru)
BR (1) BR112014028632B1 (ru)
CA (1) CA2879816C (ru)
CL (1) CL2014003116A1 (ru)
DK (1) DK2870141T3 (ru)
EA (1) EA029044B1 (ru)
ES (1) ES2657942T3 (ru)
IL (1) IL235742A0 (ru)
IN (1) IN2014DN10658A (ru)
MX (1) MX356846B (ru)
MY (1) MY169094A (ru)
NZ (1) NZ702073A (ru)
SG (1) SG11201407703QA (ru)
WO (1) WO2013171334A1 (ru)
ZA (1) ZA201409220B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6484168B2 (ja) * 2012-05-18 2019-03-13 ヴィロノヴァ・インフルエンザ・アクチェボラーグ 抗ウイルス活性を有するメタンチオン化合物
CN107056762B (zh) * 2016-12-22 2020-08-28 四川百利药业有限责任公司 一种用作抗流感病毒的双羰基类似物
WO2021204923A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Antiviral agents
WO2021204924A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Compounds for use in the treatment of hypercytokinemia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642390B2 (en) 2001-07-11 2003-11-04 Lexicon Pharmaceuticals, Inc. One step synthesis of 1,2,3-triazole carboxylic acids
AU2004218260A1 (en) * 2003-01-28 2004-09-16 Aventis Pharma S.A. N-aryl heteroaromatic products, compositions containing same and use thereof
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
RU2012104214A (ru) 2009-08-05 2013-09-10 Верситек Лимитед Противовирусные соединения и способы их получения и применения
BR112013007651A2 (pt) * 2010-09-28 2019-09-24 Bristol-Myers Squibb Company análogos de piperazina com grupos heteroarila substituídos como antivirais de influenza de amplo espectro
EP2484655A1 (en) 2011-02-04 2012-08-08 Vironova AB A thionation process and a thionating agent
JP6484168B2 (ja) * 2012-05-18 2019-03-13 ヴィロノヴァ・インフルエンザ・アクチェボラーグ 抗ウイルス活性を有するメタンチオン化合物
JP6762767B2 (ja) * 2016-06-01 2020-09-30 キヤノン株式会社 撮像素子、撮像装置、および撮像信号処理方法

Also Published As

Publication number Publication date
US9359310B2 (en) 2016-06-07
WO2013171334A1 (en) 2013-11-21
JP6484168B2 (ja) 2019-03-13
BR112014028632A2 (pt) 2017-06-27
KR102092207B1 (ko) 2020-03-23
CL2014003116A1 (es) 2015-08-07
KR20150012289A (ko) 2015-02-03
US20150133468A1 (en) 2015-05-14
EP2870141A1 (en) 2015-05-13
EP2870141B1 (en) 2017-11-22
MX356846B (es) 2018-06-18
IL235742A0 (en) 2015-02-01
JP2015517516A (ja) 2015-06-22
SG11201407703QA (en) 2015-01-29
MY169094A (en) 2019-02-18
ES2657942T3 (es) 2018-03-07
CN104540810A (zh) 2015-04-22
MX2014014007A (es) 2015-05-11
NZ702073A (en) 2017-07-28
BR112014028632B1 (pt) 2020-01-28
DK2870141T3 (da) 2018-01-29
CA2879816C (en) 2020-07-07
JP2018065817A (ja) 2018-04-26
ZA201409220B (en) 2016-08-31
AU2013261735A1 (en) 2015-01-22
HK1210165A1 (en) 2016-04-15
EA029044B1 (ru) 2018-02-28
BR112014028632A8 (pt) 2018-04-03
IN2014DN10658A (ru) 2015-08-28
CA2879816A1 (en) 2013-11-21
AU2013261735B2 (en) 2017-07-20
CN104540810B (zh) 2017-01-18

Similar Documents

Publication Publication Date Title
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
CR20140231A (es) Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih
EA201690473A1 (ru) Комбинированный состав двух противовирусных соединений
UA114087C2 (xx) Похідні піридину
EA201692219A1 (ru) Способы получения противовирусных соединений
CY1116987T1 (el) Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
UY34851A (es) Inhibidores macrocíclicos de virus flaviviridae
EA201590868A1 (ru) Противовирусные соединения
EA201301209A1 (ru) Производные пирролотриазинона в качестве ингибиторов p13k
BR112014011351A2 (pt) inibidores de acc e usos dos mesmos
EA201790661A2 (ru) Ингибиторы вируса гепатита c
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
BR112015028152A2 (pt) inibidores de acc e usos dos mesmos
EA201591064A1 (ru) Новые производные пиридина
EA201490846A1 (ru) Новые производные арилхинолина
EA201490643A1 (ru) Новые производные бетулиновой кислоты с противовирусной активностью
UY34057A (es) Inhibidores del virus de la hepatitis c
PY1153144A (es) Inhibidores macrocíclicos de virus flaviviridae
JO3063B1 (ar) مركب مبتكر وطرق لانتاجه
BR112016009757A8 (pt) “inibidores do vírus sincicial respiratório com base em quinazolina”
EA201590561A1 (ru) Пролекарства аминохиназолинового ингибитора киназы
EA201500931A1 (ru) Производные пиридин-4-ила
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM